New app aims to empower hepatitis delta patients in their own care

NCT ID NCT07442760

Recruiting now Knowledge-focused Sponsor: FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a mobile app called ePro-Diary HDV for people with hepatitis Delta, a rare but serious liver disease. The app helps patients track their health, communicate with doctors, and remember appointments. Researchers want to see if using the app helps patients attend more follow-up visits and improves their quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: mobile application (ePro-Diary HDV)
What this could lead to: If successful, this app could help patients with hepatitis Delta stay on track with their care and improve communication with their doctors.
What could go wrong: This is a small, early study testing a digital tool, not a new drug. The app may not work for everyone or may not improve health outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HDV are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hepatitis hepatitis D virus infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HDV HDV INFECTION HEPATITIS

Contacts and locations

Locations

ASST-Papa Giovanni XXIII
RECRUITING

Bergamo, Italy, 24127, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.